Menopause Health Center
Support & Resources
Find support from others coping with menopause and its complication, ask the experts your questions, and get more menopause information from other web sites that can help.
Finding Help
Find menopause help here.
Resources
Here are twenty menopause-related associations with more of the menopause information you need.
Build on your menopause knowledge with articles, guidebooks, newsletters, reviews and more from these menopause specialists. This link takes you to the group's web site.
This nonprofit group provides information and educational programs about menopause. The link below takes you to its web site.
To help you make the decision about hormone therapy, the National Institutes of Health have put together a fact sheet on postmenopausal hormone.
This National Institutes of health site offers an overview of menopause, its symptoms, treatment, and more in printer-friendly format. This link takes you to the web site.
Find brochures -- in English and Spanish -- covering the basics of menopause and hormones.
Interested in joining a clinical trial researching menopause, menopause treatments, and more? This site offers an extensive list of menopause-related clinical trials searching for participants. This link takes you to the web site.
This site offers links to information on menopause including the latest news, coping strategies, symptoms, treatment, clinical trials, and menopause and alternative medicine.
Want current and advanced reading on new findings from the Women's Health Initiative and other studies offering information about the risks and benefits of long-term menopausal hormone therapy? You can find it here.
This directory quickly helps you locate physicians near you.
An organization for women (and men) age 50 and older, the AARP was formerly called the American Association of Retired Persons. This link will take you to its web site.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

